Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
The free Covid-19 booster dose will be part of a special drive that will continue for 75 days
India should review its vaccine policy to favour the safest vaccine of all the vaccines that have been approved for the coronavirus, says expert.
Booster shots for healthcare and frontline workers to start from Jan 10; those above 60, with comorbities, eligible too.
Vaccine availability will not be an issue though India requires about 50 crore additional doses for the two categories cleared for booster doses.